期刊文献+

甲型流感H3抗原在毕赤酵母系统中的优化表达与纯化

Optimized Expression and Purification of Influenza H3 Antigen in Pichia pastoris
下载PDF
导出
摘要 选用甲型流感H3N2亚型的代表株作为研究对象,基于对H3蛋白二级结构的分析预测和密码子使用频率曲线,对其基因序列进行了科学的密码子优化设计。以密码子优化的力度与局部二级结构混乱度成反比为原则,兼顾表达效率和正确的结构与功能,将优化后的H3序列克隆至表达载体pPICZα,电转入毕赤酵母系统中。经甲醇诱导使H3蛋白在毕赤酵母中高效分泌表达,通过聚丙烯酰胺凝胶电泳(SDS-PAGE)和蛋白质印迹法(Western blot)鉴定其表达,同时筛选高拷贝菌株。最后对该菌株培养发酵,30℃甲醇诱导72 h后收集发酵的上清液,采用10 kD膜包过滤对其浓缩,经钴柱亲和层析等手段得到了H3蛋白的单一条带,并通过Western blot确认。纯化获得的H3抗原溶液本身不表现出血凝活性,但是与镍柱填料结合富集后表现出一定程度的血凝活性。本研究为流感病毒H3抗原在毕赤酵母系统中的重组表达和后续疫苗研发提供了基础。 In this study,a representative H3N2 influenza A strain was selected.Based on the analysis and prediction of the secondary structure of H3 protein and the codon usage frequency curve,the codons of H3 gene were optimized scientifically.Based on the principle that the intensity of codon optimization is inversely proportional to the disorder degree of local secondary structure,both expression efficiency and correct structure are considered.Then the optimized H3 sequence was cloned into the pPICZαexpression vector and transferred into Pichia pastoris by electroporation.After methanol induction,the H3 protein was expressed and secreted efficiently in P.pastoris.The expression of H3 was identified by coomassian bright blue staining and Western blot,and high copy strains were screened.Finally,the strain was cultured and fermented in shaking flask.After induced by methanol at 30℃for 72 h,the supernatant of fermentation was collected and concentrated by 10 kD membrane filtration.The purification of H3 recombinant protein was obtained by cobalt column affinity chromatography,and confirmed by coomassian bright blue staining and Western blot.The purified H3 antigen solution did not show haemagglutination activity,however,the nickel column bound H3 showed some to a certain extent.Our study laid a foundation for the recombinant production of H3 in P.pastoris and future vaccine development.
作者 陈溥 李安娜 汤岩松 龙浩雨 刘坤山 周勉 CHEN Pu;LI Anna;TANG Yansong;LONG Haoyu;LIU Kunshan;ZHOU Mian(State Key Laboratory of Bioreactor Engineering,East China University of Science and Technology,Shanghai 200237,China)
出处 《激光生物学报》 CAS 2021年第5期422-428,共7页 Acta Laser Biology Sinica
基金 国家重点研发计划“合成生物学”重点专项项目(2018YFA0900300) 上海市青年科技启明星计划项目(19QA1402600) 大学生创新创业计划项目(S19017) 国家自然科学基金青年项目(31600056)。
关键词 甲型流感 H3N2 血凝素 亚单位疫苗 毕赤酵母 密码子偏好 influenza A H3N2 hemagglutinin subunit vaccine Pichia pastoris codon bias
  • 相关文献

参考文献2

二级参考文献65

  • 1Zhou J, Wang D, Gao R, et al. Biological features ofnovel avain influenza A ( H7N9 ) virus C J] . Nature,2013,25;499(7459):500-503.
  • 2Corti D, Voss J,Gamblin S J, et al. A neutralizing anti-body selected from plasma cells that binds to group 1and group 2 influenza A hemagglutinins [J] . Science,2011, 333(6044): 850-856.
  • 3McMichael A J,Gotch F M,Noble G R. et al. Cyto-toxic T-cell immunity to influenza [J]. N Engl J Med,1983. 309(1) : 13-17.
  • 4Altstein A D’Gitelman A K.Smirnov Y A,et al. Immu-nization with influenza a NP-expressing vacinia virus re-combinant protects mice against experimental infectionwith human and avian influenza virus [J]. Arch Virus,2006,151(5):921-931.
  • 5Barefoot B E,Sample C J, Ramsburg E A. Recombinantvesicular stomatitis virus expressing influenza nucleo-protein induces CD8 T-cell responses that enhance anti-body-mediated protection after lethal challenge with in-fluenza virus [J]. Clin Vaccine Immunol, 2009, 16 (4):488-498.
  • 6Huang Baoying, Wang Wenling, Li Renqing, et al. In-fluenza A virus nucleoprotein derived from Escherichiacoli or recombinant vaccinia(Tiantan) virus elicits robustcross-protection in mice[J]. Virol J, 2012,9:322,1-13.
  • 7Andres G. Grandea,Ole A. Olsen,Yoshihiro Kawao-ka. et al. Human antibodies reveal a protective epitopethat is highly conserved among human and nonhumaninfluenza A viruses[J]. PNAS,2010,107(28) : 12658-12663.
  • 8Reese K A,Lupfer C, Johnson R C,et al. A Novel Lac-tococcal Vaccine Expressing a Peptide from the M2 An-tigen of H5N2 Highly Pathogenic Avian Influenza A Vi-rus Prolongs Survival of Vaccinated Chickens [J]. VetMedlnt,2013:316926. doi; 10. 1155/2013/316926.
  • 9Gao X,Wang W, Li Y,et al. Enhanced Influenza VLPvaccines comprising matrix-2 ectodomain and nucleo-protein epitopes protects mice from lethal challenge[J].Antiviral Res, 2013 ,98(1) :4-ll.
  • 10Schotsaert M,De Filette M,Fiers,et al. Universal M2ectodomain-based influenza a vaccines: Preclinical andclinical development[J]. Expert Rev Vaccines, 2009,8(4): 499-508.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部